Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Balog

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 8, 2020
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophyJessica R Terrill, Basma A Al-Mshhdani, Marisa N Duong, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2018
Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsDavid K Williams, Jay A Markwalder, Aaron J Balog, et al.
Skeletal Muscle|April 6, 2016
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contracturesJoe N Kornegay, Daniel J Bogan, Janet R Bogan, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Molecular Psychiatry|May 25, 2011
A cooperative interaction between LPHN3 and 11q doubles the risk for ADHDM Jain, J I Vélez, M T Acosta, et al.
Science Translational Medicine|January 4, 2023
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M Birch, Michael W Lawlor, Thomas J Conlon, et al.
Molecular Psychiatry|February 17, 2010
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medicationM Arcos-Burgos, M Jain, M T Acosta, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Plos One|October 8, 2020
Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophyJessica R Terrill, Basma A Al-Mshhdani, Marisa N Duong, et al.
Bioorganic & Medicinal Chemistry Letters|February 6, 2018
Development of a series of novel o-phenylenediamine-based indoleamine 2,3-dioxygenase 1 (IDO1) inhibitorsDavid K Williams, Jay A Markwalder, Aaron J Balog, et al.
Skeletal Muscle|April 6, 2016
Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contracturesJoe N Kornegay, Daniel J Bogan, Janet R Bogan, et al.
Bioorganic & Medicinal Chemistry Letters|April 13, 2023
Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1Jay A Markwalder, Aaron J Balog, David K Williams, et al.
Molecular Psychiatry|May 25, 2011
A cooperative interaction between LPHN3 and 11q doubles the risk for ADHDM Jain, J I Vélez, M T Acosta, et al.
Science Translational Medicine|January 4, 2023
Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophySharla M Birch, Michael W Lawlor, Thomas J Conlon, et al.
Molecular Psychiatry|February 17, 2010
A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medicationM Arcos-Burgos, M Jain, M T Acosta, et al.
Pageof 4